Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis.
Valeria
V
Criscuoli
Filippo
F
Mocciaro
Ambrogio
A
Orlando
Maria Rosa
MR
Rizzuto
Maria Concetta
MC
Renda
Mario
M
Cottone
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000276:immunology; D006801:Humans; D000069285:Infliximab; D007937:Leukapheresis; D014779:Virus Replication / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab